Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arsenic and Immune Response to Influenza Vaccination in Pregnant Women and Newborns

NCT03930017 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.

NCT NCT03930017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03930017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arsenic and Immune Response to Influenza Vaccination in Pregnant Women and Newborns
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Phase
Observational
Overall status
Completed
Start date
October 14, 2018
Completion date
January 6, 2020
Enrollment
784 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arsenic--toxicology, immunologic disorders complicating pregnancy, influenza, micronutrient deficiency, vaccine response impaired